Administration of human immunoglobulin suppresses development of murine systemic vasculitis induced with Candida albicans water-soluble fraction: an animal model of Kawasaki disease

References

• Kawasaki T. Acute febrile muco-cutaneous lymph node syn-drome in young children with unique digital desquamation. Jpn J Allergol. 1967;16:178–222.
   PubMedGoogle Scholar
• Kawasaki T, Kosaki F, Okawa S, Shigematsu I, Yanagawa H. New infantile acute febrile mucocutaneous lymph node syndrome (MLNS) prevailing in Japan. Pediatrics. 1974;54:271–6.
   Google Scholar
• Nakamura Y, Yashiro M, Uehara R, Oki I, Kayaba K, Yanagawa H. Increasing incidence of Kawasaki disease in Japan: nationwide survey. Pediatr Int. 2008;50:287–90.
   PubMed Web of Science ®Google Scholar
• Naoe S, Takahashi K, Masuda H, et al. Kawasaki disease with particular emphasis on arterial lesions. Acta Pathol Jpn. 1991;41:785–97.
   PubMedGoogle Scholar
• Murata H. Experimental Candida-induced arteritis in mice. Relation to arteritis in the mucocutaneous lymph node syndrome. Microbiol Immunol. 1979;23:825–31.
   PubMed Web of Science ®Google Scholar
• Murata H, Iijima H, Naoe S, Atobe T, Uchiyama S, Arakawa S. The pathogenesis of experimental arteritis induced by Candida alkali extract in mice. Jpn J Exp Med. 1987;57:305–13.
   PubMedGoogle Scholar
• Takahashi K, Oharaseki T, Wakayama M, Yokouchi Y, Naoe S, Murata H. Histopathological features of murine systemic vascu-litis caused by Candida albicans extract—an animal model of Kawasaki disease. Inflamm Res. 2004;53:72–7.
   PubMed Web of Science ®Google Scholar
• Kurihara K, Miura NN, Uchiyama M, Ohno N, Adachi Y, Aizawa M, et al. Measurement of blood clearance time by Limulus G test of Candida water-soluble polysaccharide fraction, CAWS, in mice. FEMS Immunol Med Microbiol. 2000;29:69–76.
   PubMedGoogle Scholar
• Kurihara K, Shingo Y, Miura NN, Hone S, Usui Y, Adachi Y, et al. Effect of CAWS, a mannoprotein—beta-glucan complex of Candida albicans, on leukocyte, endothelial cell, and platelet functions in vitro. Biol Pharm Bull. 2003;26:233–40.
   PubMed Web of Science ®Google Scholar
• Uchiyama M, Ohno N, Miura NN, Adachi Y, Aizawa MW, Tamura H. Chemical and immunochemical characterization of limulus factor G-activating substance of Candida spp. FEMS Immunol Med Microbiol. 1999;24:411–20.
   PubMedGoogle Scholar
• Miura NN, Shingo Y, Adachi Y, Okawara IA, Oharaseki T, Takahashi K, et al. Induction of coronary arteritis with admin-istration of CAWS (Candida albicans water soluble fraction) depending on mouse strains. Immunopharmacol Immunotoxicol. 2004;26:527–43.
   PubMed Web of Science ®Google Scholar
• Miura NN, Harada T, Shinohara H, Kurihara K, Adachi Y, Okawara IA, et al. Lethal and severe coronary arteritis in DBA/2 mice induced by fungal pathogen, CAWS, Candida albicans water-soluble fraction. Atherosclerosis. 2006;186:310–20.
   PubMed Web of Science ®Google Scholar
• Oharaseki T, Kameoka Y, Kura F, Persad AS, Suzuki K, Naoe S. Susceptibility loci to coronary arteritis in animal model of Kawasaki disease induced with Candida albicans-derived sub-stances. Microbiol Immunol. 2005;49:181–9.
   PubMed Web of Science ®Google Scholar
• Okawara Al, Miura NN, Oharaseki T, Takahashi K, Okumra A, Tachikawa H, et al. Neutrophil activation and arteritis induced by C. albicans water-soluble mannoprotein-/3-glucan complex (CAWS). Exp Mol Pathol. 2007;82:220–6.
   Google Scholar
• Furusho K, Kamiya T, Nakano H, Kiyosawa N, Shinomiya K, Hayashidera T, et al. High-dose intravenous gammaglobufin for Kawasaki disease. Lancet. 1984;10:1055–8.
   Google Scholar
• Newburger JW, Takahashi M, Beiser AS, Burns JC, Bastian J, Chung KJ, et al. A single intravenous infusion of gamma globulin as compared with four infusions in the treatment of acute Kawasaki syndrome. N Engl J Med. 1991;324:1633–9.
   PubMed Web of Science ®Google Scholar
• Daniefi MG, Cappelli M, Malcangi G, Logullo F, Salvi A, Da-nieli G. Long term effectiveness of intravenous immunoglobulin in Churg-Strauss syndrome. Ann Rheum Dis. 2004;63:1649–54.
   Google Scholar
• Jayne DR, Lockwood CM. Intravenous immunoglobulin as sole therapy for systemic vasculitis. Br J Rheumatol. 1996;35:1150–3.
   PubMedGoogle Scholar
• Levy Y, Uziel Y, Zandman GG, Amital H, Sherer Y, Langevitz P, et al. Intravenous immunoglobulin in peripheral neuropathy associated with vasculitis. Ann Rheum Dis. 2003;62:1221–3.
   PubMed Web of Science ®Google Scholar
• Ihara IT, Ono T, Nogaki F, Suyama K, Tanaka M, Yonemoto S, et al. Clinical efficacy of intravenous immunoglobulin for patients with MPO-ANCA-associated rapidly progressive glomerulonephritis. Nephron Clin Pract. 2006;102:c35–42.
   Google Scholar
• Jayne DR, Chapel H, Adu D, Misbah S, O'Donoghue D, Scott D, et al. Intravenous immunoglobulin for ANCA-associated sys-temic vasculitis with persistent disease activity. Q J Med. 2000;93:433–9.
   Google Scholar
• Suzuki K, Okazaki T. Contribution of myeloperoxidase in vas-culitis development. Jpn J Infect Dis. 2004;57:52–4.
   PubMed Web of Science ®Google Scholar
• Okawara IA, Oharaseki T, Takahashi K, Hashimoto Y, Aratani Y, Koyama H, et al. Contribution of myeloperoxidase to coronary artery vasculitis associated with MPO-ANCA production. Inflammation. 2001;25:381–7.
   PubMed Web of Science ®Google Scholar
• Newburger JW, Takahashi M, Burns JC, Beiser AS, Chung KJ, Duffy CE, et al. The treatment of Kawasaki syndrome with intravenous gamma globulin. New Engl J Med. 1986;315:341–6.
   PubMed Web of Science ®Google Scholar
• Fujii A, Tomizawa A, Arimura Y, Nagasawa T, Ohashi YY, Hiyama T, et al. Epitope analysis of myeloperoxidase (MPO) specific antineutrophil cytoplasmic autoantibodies (ANCA) in MPO-ANCA-associated glomerulonephritis. Clin Nephrol. 2000; 53:242–52.
   PubMed Web of Science ®Google Scholar
• Tomizawa K, Mine E, Fujii A, Ohashi YY, Yamagoe S, Hashimoto Y, et al. A panel set for epitope analysis of myelo-peroxidase (MPO)-specific antineutrophil cytoplasmic antibody MPO-ANCA using recombinant hexamer histidine-tagged MPO deletion mutants. J Clin Immunol. 1998;18:142–52.
   PubMed Web of Science ®Google Scholar
• Suzuki K, Kobayashi S, Yamazaki K, Gondo M, Tomizawa K, Arimura Y, et al. Analysis of risk epitopes of anti-neutrophil antibody MPO-ANCA in vasculitis in Japanese population. Microbiol Immunol. 2007;51:1215–20.
   PubMed Web of Science ®Google Scholar